International validation of a patient reported experience measure for GI endoscopy
D
Douglas Rex, MD
Primary Investigator
Enrolling By Invitation
18-100 years
All
Phase
N/A
220 participants needed
2 Locations
Overview
Understanding patient experience at colonoscopy is important for quality of endoscopic practice and to maximize participation in screening programs for colorectal cancer. The Newcastle ENDOPREM™ has been tested and validated in the UK. It is important to study whether this tool is valid when applied in different languages and different practice settings.
Description
Researchers will ask 20 participants to complete the Newcastle ENDOPREM questionnaire form and to attend either a face to face, teleconference or telephone ‘debrief’ interview with a researcher to assess the appropriateness and relevance of the questions. After the interviews, questionnaires will be returned to the research team within two weeks of the colonoscopy. The questionnaire form might be modified according to feedback from the participants.
During the final phase, 200 participants will be given the new questionnaires to fill at home and return to the research team within two weeks of colonoscopy. We expect this phase to last 6 months.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
colorectal cancer
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria:
- Undergoing colonoscopy at University Hospital or Spring Mill Surgery Center
- Able to give consent
Exclusion Criteria:
- Unable to consent
- Undergone a procedure other than colonoscopy
- Have difficulty with conversing in the language of the Newcastle ENDOPREM
Updated on
15 May 2024.
Study ID: 11759, GI-NEWCASTLE-ENDOPREM
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
